Metraipolis › archive › dc_dff9625463a8
Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis — Europe PMC PMID:42256566
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42256566
- DOI
- 10.3389/fneur.2026.1842388
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T10:13:38.822Z
- SHA-256 of the archived text
47a8f009c02802ac03037e56d11886648cc5cb7d6561edcd7637a638bcc45166- Stable URL of this page
https://metraipolis.com/documento/dc_dff9625463a8
How to cite
Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis — Europe PMC PMID:42256566 — Europe PMC (en), https://europepmc.org/article/MED/42256566 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dff9625463a8 (Metraipolis archive dc_dff9625463a8, sha256 47a8f009c02802ac03037e56d11886648cc5cb7d6561edcd7637a638bcc45166)
BibTeX
@misc{dcdff9625463a8,
title = {Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis — Europe PMC PMID:42256566},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42256566},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dff9625463a8; sha256 47a8f009c02802ac03037e56d11886648cc5cb7d6561edcd7637a638bcc45166},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42256566. Agents can read the archived copy with the MCP tool read_document.